AU2017340126B2 - Compositions comprising hydroxytyrosol and boswellic acid - Google Patents

Compositions comprising hydroxytyrosol and boswellic acid Download PDF

Info

Publication number
AU2017340126B2
AU2017340126B2 AU2017340126A AU2017340126A AU2017340126B2 AU 2017340126 B2 AU2017340126 B2 AU 2017340126B2 AU 2017340126 A AU2017340126 A AU 2017340126A AU 2017340126 A AU2017340126 A AU 2017340126A AU 2017340126 B2 AU2017340126 B2 AU 2017340126B2
Authority
AU
Australia
Prior art keywords
hydroxytyrosol
keto
acetyl
composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017340126A
Other languages
English (en)
Other versions
AU2017340126A1 (en
Inventor
David Griffin
Todd Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutramax Laboratories Inc
Original Assignee
Nutramax Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutramax Laboratories Inc filed Critical Nutramax Laboratories Inc
Publication of AU2017340126A1 publication Critical patent/AU2017340126A1/en
Application granted granted Critical
Publication of AU2017340126B2 publication Critical patent/AU2017340126B2/en
Priority to AU2023203427A priority Critical patent/AU2023203427B2/en
Priority to AU2025202875A priority patent/AU2025202875A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2017340126A 2016-10-04 2017-04-21 Compositions comprising hydroxytyrosol and boswellic acid Active AU2017340126B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2023203427A AU2023203427B2 (en) 2016-10-04 2023-05-31 Compositions comprising hydroxytyrosol and boswellic acid
AU2025202875A AU2025202875A1 (en) 2016-10-04 2025-04-23 Compositions comprising hydroxytyrosol and boswellic acid

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662403807P 2016-10-04 2016-10-04
US62/403,807 2016-10-04
PCT/US2017/028857 WO2018067200A1 (en) 2016-10-04 2017-04-21 Compositions comprising hydroxytyrosol and boswellic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023203427A Division AU2023203427B2 (en) 2016-10-04 2023-05-31 Compositions comprising hydroxytyrosol and boswellic acid

Publications (2)

Publication Number Publication Date
AU2017340126A1 AU2017340126A1 (en) 2019-04-11
AU2017340126B2 true AU2017340126B2 (en) 2023-03-02

Family

ID=58664857

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2017340126A Active AU2017340126B2 (en) 2016-10-04 2017-04-21 Compositions comprising hydroxytyrosol and boswellic acid
AU2023203427A Active AU2023203427B2 (en) 2016-10-04 2023-05-31 Compositions comprising hydroxytyrosol and boswellic acid
AU2025202875A Pending AU2025202875A1 (en) 2016-10-04 2025-04-23 Compositions comprising hydroxytyrosol and boswellic acid

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2023203427A Active AU2023203427B2 (en) 2016-10-04 2023-05-31 Compositions comprising hydroxytyrosol and boswellic acid
AU2025202875A Pending AU2025202875A1 (en) 2016-10-04 2025-04-23 Compositions comprising hydroxytyrosol and boswellic acid

Country Status (9)

Country Link
US (3) US11241444B2 (cg-RX-API-DMAC7.html)
EP (2) EP3522874B1 (cg-RX-API-DMAC7.html)
JP (4) JP7079551B2 (cg-RX-API-DMAC7.html)
CN (2) CN109789110A (cg-RX-API-DMAC7.html)
AU (3) AU2017340126B2 (cg-RX-API-DMAC7.html)
CA (1) CA3039233A1 (cg-RX-API-DMAC7.html)
ES (1) ES3040765T3 (cg-RX-API-DMAC7.html)
PL (1) PL3522874T3 (cg-RX-API-DMAC7.html)
WO (1) WO2018067200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109789110A (zh) 2016-10-04 2019-05-21 纽崔玛氏科技有限责任公司 包含羟基酪醇和乳香酸的组合物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020588A1 (en) * 2004-08-09 2006-02-23 Creagri, Inc. Olive compositions and methods for treating inflammatory conditions
WO2008006581A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
US20140155339A1 (en) * 2012-11-30 2014-06-05 Darlene E. McCord Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
US20150290270A1 (en) * 2008-09-15 2015-10-15 Laila Nutraceuticals Synergistic anti-inflammatory compositions comprising boswellia serrata extract

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358542B2 (en) 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
WO2002018310A1 (en) 2000-09-01 2002-03-07 Creagri, Inc. Method of obtaining a hydroxytyrosol-rich composition from vegetation water
US7713569B2 (en) 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
WO2003068171A2 (en) 2002-02-13 2003-08-21 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
WO2003077860A2 (en) 2002-03-13 2003-09-25 Biophysica, Inc. BOSWELLIN COMPOSITIONS ENHANCED WITH 3-β-ACETYL-11-KETO-β-BOSWELLIC ACID (“AKBA”), INDUSTRIAL MANUFACTURE AND THEIR USES
EP1582512A1 (en) 2004-03-31 2005-10-05 Cognis IP Management GmbH Process for obtaining hydroxytyrosol from olive leaves extracts
WO2005123649A1 (en) 2004-06-18 2005-12-29 Ganga Raju Gokaraju NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-β-BOSWELLIC ACID
WO2008006582A1 (en) 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
JP2008120716A (ja) 2006-11-10 2008-05-29 Eisai Food Chemical Kk 抗炎症剤
CN102451428A (zh) * 2010-10-14 2012-05-16 中国中医科学院广安门医院 可用于治疗类风湿关节炎的中药组合物
CN109789110A (zh) 2016-10-04 2019-05-21 纽崔玛氏科技有限责任公司 包含羟基酪醇和乳香酸的组合物
US10342802B2 (en) 2016-10-04 2019-07-09 Nutramax Laboratories, Inc. Compositions comprising hydroxytyrosol and boswellic acid

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006020588A1 (en) * 2004-08-09 2006-02-23 Creagri, Inc. Olive compositions and methods for treating inflammatory conditions
WO2008006581A2 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders
US20150290270A1 (en) * 2008-09-15 2015-10-15 Laila Nutraceuticals Synergistic anti-inflammatory compositions comprising boswellia serrata extract
US20140155339A1 (en) * 2012-11-30 2014-06-05 Darlene E. McCord Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition

Also Published As

Publication number Publication date
AU2023203427B2 (en) 2025-02-06
AU2023203427A1 (en) 2023-06-29
JP2023159387A (ja) 2023-10-31
JP7341596B2 (ja) 2023-09-11
JP2024166415A (ja) 2024-11-28
JP2019529482A (ja) 2019-10-17
EP4623994A3 (en) 2025-11-19
US20220110946A1 (en) 2022-04-14
EP3522874B1 (en) 2025-07-02
EP4623994A2 (en) 2025-10-01
JP2022110125A (ja) 2022-07-28
ES3040765T3 (en) 2025-11-04
AU2017340126A1 (en) 2019-04-11
PL3522874T3 (pl) 2025-10-06
JP7562225B2 (ja) 2024-10-07
US11241444B2 (en) 2022-02-08
AU2025202875A1 (en) 2025-05-15
CN120241745A (zh) 2025-07-04
EP3522874A1 (en) 2019-08-14
JP7079551B2 (ja) 2022-06-02
US20200222424A1 (en) 2020-07-16
CA3039233A1 (en) 2018-04-12
CN109789110A (zh) 2019-05-21
US20240285648A1 (en) 2024-08-29
US11980624B2 (en) 2024-05-14
WO2018067200A1 (en) 2018-04-12

Similar Documents

Publication Publication Date Title
Jerosch Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially Omega‐3 fatty acids
US20250152554A1 (en) Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
AU2025202875A1 (en) Compositions comprising hydroxytyrosol and boswellic acid
US10722524B2 (en) Compositions comprising hydroxytyrosol and boswellic acid
US11426363B2 (en) Compositions including cannabis and avocado/soybean unsaponifiables and methods of use
St. Blanc et al. Effects of supplements containing turmeric and devil’s claw on equine gastric ulcer scores and gastric juice pH
US20200384052A1 (en) Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
CN115023150B (zh) 硫酸软骨素合成促进用组合物
Neagu et al. The management of arthritic pain in dogs–a review
HK40079603B (zh) 硫酸软骨素合成促进用组合物
NZ618389B2 (en) Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)